1st Half revenue grew 452.1% to $32.3 million YoY IM8 achieved $5.9 million revenue in August 2025, representing a CAGR1 of over 3,100% Prenetics increases FY2025 revenue guidance range of $85 – $100 million Prenetics provides update on Bitcoin Treasury, …

… billion within three years. The pharma disclosed the development in its … the notice. Pakistan’s Citi Pharma completes first-ever export to … commencing by the end of Q4 of FY 2025-26 and … an increase in its gross profit margin to approximately 25% reflecting …

… for its fiscal fourth quarter and full year … outlook, including future revenues and future earnings; the … market developments; new pharmacy services; and the effects … 30, 2024                 Revenues               Capitation revenue $ 221,060     $ 199 …

… 3 billion collaboration with Zealand Pharma (NASDAQ Copenhagen: ZEAL) to … according to Benzinga, described the drugmaker’s actions as “tough, … investors about its expected operating profit growth this year, to … ($157.092 million) in Q4, and DKK 8 billion ($ …

… (NASDAQ:INNV) Q4 2025 Earnings Call … fourth quarter capped a strong year of consistent execution. Revenue … million. We expect profitability to build through … pharmacy services, and fleet costs inclusive of contract transportation. For the fourth quarter …

Danish pharmaceutical giant Novo Nordisk has … Novo may issue a fourth profit warning when reporting third- … DKK 1 billion in the fourth quarter and confirmed that these … competitive and consumer-driven global pharmaceutical market while maintaining its …

… years, as the Danish pharma became a powerhouse in obesity … Lilly and pressure from compounding pharmacies creating knockoffs of its … $13.5 billion in the fourth quarter of 2024. That trend reversed … beginning of this year, with revenue landing at $12.1 …

… crowns of savings in the fourth quarter, it said. It expects … open image in gallery Operating profit growth this year is now … per cent (Reuters) Operating profit growth this year is now … off the drugmaker';s market value after Novo issued a profit warning …

… reported results for the fourth quarter of fiscal 2025 on … states, insourcing more pharmacy operations, and tightening … Excluding these events, core profitability metrics showed clear improvement. … visibility into future revenue and reduces the administrative …

… Q4 FY 2025, from $14.8 million in the fourth quarter … diluted share in the fourth quarter of the prior fiscal … Electromed – posting record revenues and profitability as our diverse growth … including new drug or pharmaceutical discoveries; adverse economic and …